Publications by authors named "S Roehrig"

Claim this Profile
D
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders.
Susanne Roehrig, Jens Ackerstaff, Eloísa Jiménez Núñez, Henrik Teller, Pascal Ellerbrock

J Med Chem· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa.
Stefan Heitmeier, Mayken Visser, Adrian Tersteegen, Julia Dietze-Torres, Julia Glunz, Susanne Roehrig

J Thromb Haemost· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Pharmacological Characterization of a Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics.
Alexander Hillisch, Kersten M Gericke, Swen Allerheiligen, Susanne Roehrig, Martina Schaefer

J Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial.
Nadir Kharma, Stefan Roehrig, Ahmed Atef Shible, Moustafa Sayed Elshafei, Dema Osman

Trials· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Stefan Roehrig, Ali Ait Hssain, Nabil Al Hamid Shallik, Ingi Mohamed A Elsaid, Salma Faisal Mustafa

Trials· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis